Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Kedudukan dalam Saham #29675
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Harga Saham
$0.20877985
Modal Pasaran
$20.11M
Perubahan (1 hari)
-3.03%
Perubahan (1 tahun)
-66.13%
Negara
JP
Perdagangan Modalis Therapeutics Corporation (4883)

Kategori

Sejarah pecahan saham untuk Modalis Therapeutics Corporation (4883)
Saham Modalis Therapeutics Corporation (simbol: 4883) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham 4883 yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham 4883.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH